Key statistics dashboard for LENSAR Inc (LNSR). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Stock Data
| Price | $7.09 |
| Market Cap | $87M |
| Enterprise Value | $75.8M |
| Beta | 0.98 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 5.57 |
| Price / Book | 5.84 |
| P/S | 1.44 |
| EV/EBITDA | 2.13 |
| EV/Sales | 1.26 |
| EV/FCF | -10.34 |
| P/FCF | -11.87 |
| Earnings Yield | 39.85% |
| FCF Yield | -8.43% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 47.96% |
| EBIT Margin | 52.92% |
| EBITDA Margin | 59.05% |
| Operating Margin | -13.48% |
| Net Margin | 57.57% |
| Return on Equity | 10380.25% |
| Return on Assets | 49.88% |
| Return on Invested Capital | -16.02% |
| Return on Capital Employed | -16.28% |
Financial Health
| Current Ratio | 2.39 |
| Quick Ratio | 1.13 |
| Cash Ratio | 0.69 |
| Debt / Equity | 0.16 |
| Debt / Assets | 3.42% |
| Net Debt / EBITDA | -0.31 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -2.84 |
Per-Share Data
| Revenue per share | 4.90 |
| Book Value per share | 1.21 |
| Cash per share | 1.10 |
| FCF per share | -0.60 |
| Tangible Book Value per share | 0.83 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 3 |
| Avg rating (1-5) | 0.67 |
Related companies: ANIK · ARAY · AVR · CRBP · CRDF · MXCT · OWLT
Explore sector: Healthcare · Medical - Devices
More sections of LNSR: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks